{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:16:23Z","timestamp":1783181783108,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,20]],"date-time":"2027-04-20T00:00:00Z","timestamp":1808179200000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA028796-01"],"award-info":[{"award-number":["R01AA028796-01"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/13400-1"],"award-info":[{"award-number":["2024\/13400-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2022\/02062-2"],"award-info":[{"award-number":["2022\/02062-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cct.2026.108312","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:47:39Z","timestamp":1776066459000},"page":"108312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A double-blind randomized clinical trial of zonisamide and contingency management for alcohol use disorder treatment (ZARRA) protocol"],"prefix":"10.1016","volume":"165","author":[{"given":"Paola","family":"Palombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Akana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hovland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Connor","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Chaytor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McDonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Burduli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Constantino","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2026.108312_bb0005","unstructured":"World Health Organization. (2024). Global information system on alcohol and health. World Health Organization. https:\/\/www.who.int\/data\/gho\/data\/themes\/global-information-system-on-alcohol-and-health. 2024."},{"issue":"8","key":"10.1016\/j.cct.2026.108312_bb0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.15585\/mmwr.mm7308a1","article-title":"Deaths from excessive alcohol use \u2014 United States, 2016\u20132021","volume":"73","author":"Esser","year":"2024","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.cct.2026.108312_bb0015","series-title":"Report on alcohol intake and health","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2025"},{"issue":"5","key":"10.1016\/j.cct.2026.108312_bb0020","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.amepre.2015.05.031","article-title":"2010 national and state costs of excessive alcohol consumption","volume":"49","author":"Sacks","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.cct.2026.108312_bb0025","series-title":"Understanding Alcohol use Disorder","author":"National institute on alcohol abuse and alcoholism","year":"2025"},{"issue":"6","key":"10.1016\/j.cct.2026.108312_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2017.10.032","article-title":"Alcohol and the brain: neuronal molecular targets, synapses, and circuits","volume":"96","author":"Abrahao","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.cct.2026.108312_bb0035","first-page":"1","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.cct.2026.108312_bb0040","first-page":"1775","article-title":"Medications for treating alcohol dependence","volume":"72","author":"Williams","year":"2005","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e3181db38bb","article-title":"Placebo-controlled trial of zonisamide for the treatment of alcohol dependence","volume":"30","author":"Arias","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2007.04.001","article-title":"Zonisamide decreases ethanol intake in rats and mice","volume":"87","author":"Knapp","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/alcalc\/agx003","article-title":"The impact of zonisamide on the development and course of alcohol dependence in rabbits. A pharmaco-EEG study","volume":"52","author":"Krupa-Burtnik","year":"2017","journal-title":"Alcohol Alcohol."},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JCP.0000000000000246","article-title":"Zonisamide, topiramate, and levetiracetam","volume":"35","author":"Knapp","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2026.108312_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jpsychires.2024.08.044","article-title":"Results from a randomized controlled trial of zonisamide in the treatment of alcohol use disorder","author":"Farchione","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0070","article-title":"Combined pharmacological and psychosocial interventions for alcohol use disorder","volume":"2025","author":"Minozzi","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1901\/jaba.2012.45-161","article-title":"Voucher-based reinforcement for alcohol abstinence using the ethyl-glucoronide alcohol biomarker","volume":"45","author":"Mcdonell","year":"2012","journal-title":"J. Appl. Behav. Anal."},{"issue":"4","key":"10.1016\/j.cct.2026.108312_bb0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1176\/appi.ajp.2016.16050627","article-title":"A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness","volume":"174","author":"McDonell","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.cct.2026.108312_bb0085","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/add.15349","article-title":"The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community","volume":"116","author":"McDonell","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2026.108312_bb0090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cct.2018.04.010","article-title":"Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness","volume":"69","author":"Oluwoye","year":"2018","journal-title":"Contemp. Clin. Trials"},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2015.10.024","article-title":"Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders","volume":"80","author":"Kwako","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cct.2026.108312_bb0100","first-page":"8","article-title":"Commentary: addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders","author":"Ghitza","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.cct.2026.108312_bb0105","first-page":"1","article-title":"Neuroclinical framework for the role of stress in addiction","author":"Kwako","year":"2017","journal-title":"Chronic Stress."},{"issue":"7","key":"10.1016\/j.cct.2026.108312_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2016.08.029","article-title":"Reply to: Neuroclinical assessment of addiction needs to incorporate decision-making measures and ecological validity","volume":"81","author":"Kwako","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cct.2026.108312_bb0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2017.03.006","article-title":"Addictions neuroclinical assessment: a reverse translational approach","volume":"122","author":"Kwako","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06298.x","article-title":"The clinical significance of drug craving","volume":"1248","author":"Tiffany","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.cct.2026.108312_bb0125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11920-007-0050-6","article-title":"The role of stress in addiction relapse","volume":"9","author":"Sinha","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"issue":"4","key":"10.1016\/j.cct.2026.108312_bb0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1037\/a0015647","article-title":"Dynamic association between negative affect and alcohol lapses following alcohol treatment","volume":"77","author":"Witkiewitz","year":"2009","journal-title":"J. Consult. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.cct.2026.108312_bb0135","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1037\/0894-4105.21.6.778","article-title":"Response inhibition deficit is involved in poor decision making under risk in nonamnesic individuals with alcoholism","volume":"21","author":"No\u00ebl","year":"2007","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.cct.2026.108312_bb0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1521-0391.2013.12114.x","article-title":"Preliminary findings: contingency management targeting psycho-stimulant use results in secondary decreases in smoking for severely mentally ill adults","volume":"23","author":"McDonell","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.cct.2026.108312_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/SAR.S138439","article-title":"A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies","volume":"9","author":"McPherson","year":"2018","journal-title":"Subst. Abus. Rehabil."},{"issue":"05","key":"10.1016\/j.cct.2026.108312_bb0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4088\/JCP.v66n0512","article-title":"Open-label adjunctive zonisamide in the treatment of bipolar disorders","volume":"66","author":"SL","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.cct.2026.108312_bb0155","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.4088\/JCP.v67n1209","article-title":"Zonisamide in the treatment of binge eating disorder with obesity","volume":"67","author":"SL","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1176\/appi.ajp.2012.11121831","article-title":"Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness","volume":"170","author":"McDonell","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1521-0391.2013.12059.x","article-title":"Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study","volume":"23","author":"McPherson","year":"2014","journal-title":"Am. J. Addict."},{"issue":"6","key":"10.1016\/j.cct.2026.108312_bb0170","doi-asserted-by":"crossref","first-page":"858","DOI":"10.15288\/jsa.2003.64.858","article-title":"Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems","volume":"64","author":"Sobell","year":"2003","journal-title":"J. Stud. Alcohol"},{"issue":"11_supplement_3","key":"10.1016\/j.cct.2026.108312_bb0175","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182872ded","article-title":"Cognition assessment using the NIH toolbox","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"issue":"11_supplement_3","key":"10.1016\/j.cct.2026.108312_bb0180","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182872e11","article-title":"Emotion assessment using the NIH toolbox","volume":"80","author":"Salsman","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.cct.2026.108312_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2026.108312_bb0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addbeh.2016.02.035","article-title":"Additional validity evidence for the PROMIS smoking assessment toolkit","volume":"58","author":"Edelen","year":"2016","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ntr\/ntv083","article-title":"The psychometric performance of the PROMIS smoking assessment toolkit: comparisons of real-data computer adaptive tests, short forms, and mode of administration","volume":"18","author":"Stucky","year":"2016","journal-title":"Nicotine Tob. Res."},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.psychres.2012.09.034","article-title":"Assessment of self-reported negative affect in the NIH toolbox","volume":"206","author":"Pilkonis","year":"2013","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.cct.2026.108312_bb0200","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/13803395.2021.2002269","article-title":"The TestMyBrain digital neuropsychology toolkit: development and psychometric characteristics","volume":"43","author":"Singh","year":"2021","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0376-8716(03)00032-2","article-title":"Desipramine and contingency management for cocaine and opiate dependence in buprenorphine-maintained patients","volume":"70","author":"Kosten","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.cct.2026.108312_bb0215","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivant","year":"1989","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.cct.2026.108312_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15288\/jsas.2005.s15.157","article-title":"The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field","volume":"s15","author":"Johnson","year":"2005","journal-title":"J. Stud. Alcohol Suppl."},{"issue":"2","key":"10.1016\/j.cct.2026.108312_bb0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.14581\/jer.15015","article-title":"Safety and efficacy of zonisamide in patients with epilepsy: a post-marketing surveillance study","volume":"5","author":"Lee","year":"2015","journal-title":"J. Epilepsy Res."},{"issue":"9","key":"10.1016\/j.cct.2026.108312_bb0245","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.addbeh.2013.03.018","article-title":"Duration effects in contingency management treatment of methamphetamine disorders","volume":"38","author":"Roll","year":"2013","journal-title":"Addict. Behav."},{"issue":"5","key":"10.1016\/j.cct.2026.108312_bb0250","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hup.2339","article-title":"Longitudinal missing data strategies for substance use clinical trials using generalized estimating equations: an example with a buprenorphine trial","volume":"28","author":"McPherson","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0255","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/a0027146","article-title":"Missing data in substance abuse treatment research: current methods and modern approaches","volume":"20","author":"McPherson","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.cct.2026.108312_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/add.12714","article-title":"A \u2018missing not at random\u2019 (MNAR) and \u2018missing at random\u2019 (MAR) growth model comparison with a buprenorphine\/naloxone clinical trial","volume":"110","author":"McPherson","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2026.108312_bb0265","series-title":"Applied Missing Data Analysis","author":"Enders","year":"2010"},{"issue":"6","key":"10.1016\/j.cct.2026.108312_bb0270","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/00952990.2021.1969658","article-title":"Understanding low treatment seeking rates for alcohol use disorder: a narrative review of the literature and opportunities for improvement","volume":"47","author":"Venegas","year":"2021","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.cct.2026.108312_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2025.107807","article-title":"A randomized controlled trial to assess whether a telehealth-based contingency management intervention reduces alcohol use for individuals with alcohol use disorder","volume":"150","author":"Jett","year":"2025","journal-title":"Contemp. Clin. Trials"},{"issue":"2","key":"10.1016\/j.cct.2026.108312_bb0280","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1037\/0022-006X.68.2.250","article-title":"Give them prizes and they will come: contingency management for treatment of alcohol dependence","volume":"68","author":"Petry","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.cct.2026.108312_bb0285","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/add.13767","article-title":"A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor","volume":"112","author":"Barnett","year":"2017","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.cct.2026.108312_bb0290","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamapsychiatry.2020.4768","article-title":"Effect of incentives for alcohol abstinence in partnership with 3 american indian and Alaska native communities","volume":"78","author":"McDonell","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.cct.2026.108312_bb0295","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/alcalc\/agl007","article-title":"Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres experience with pharmacotherapy","volume":"41","author":"Gfx","year":"2006","journal-title":"Alcohol Alcohol."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:23:50Z","timestamp":1783178630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S1551714426000984"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108312","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A double-blind randomized clinical trial of zonisamide and contingency management for alcohol use disorder treatment (ZARRA) protocol","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108312"}}